Bartter综合征二例家系报告与CLCNKB基因突变分析

doi:10.6040/j.issn.1671-7554.0.2020.0574

摘要/Abstract

摘要： 目的探讨儿童Bartter综合征的临床特点及CLCNKB基因突变分析。方法分析两个无血缘关系的Bartter综合征家系先证者及其家庭成员的临床资料,应用过柱法提取外周血DNA,针对Bartter综合征相关突变基因的外显子编码区设计引物、扩增,对PCR产物进行直接测序,与美国生物技术信息中心中的正常序列进行BLAST比对,从而发现可能存在的基因突变,最后多重连接探针扩增技术检测是否存在大片段缺失。结果两例家系的先证者检测均示:低钾血症、碱中毒、高肾素血症、高醛固酮血症。家系1先证者发现CLCNKB基因1~3、5~6、8、10~11、13~15、17~19号外显子大片段纯合缺失,分别遗传自父母;家系2先证者发现CLCNKB基因1~3、5~6、8、10~11、13~15、17~19号外显子大片段缺失与c.1881delC(p.Thr628fs)的复合杂合突变,分别遗传自父母。结论 c.1881delC(p.Thr628fs)为移码突变,该变异国内外尚未见报道。CLCNKB基因突变为2个Bartter综合征家系的致病原因,确诊为Ⅲ型Bartter综合征,临床分型属于经典型。临床上可通过分子遗传学技术进行Bartter综合征的基因诊断,提高确诊率,及时治疗。

关键词: Bartter综合征, CLCNKB基因, 突变, 基因型

Abstract: Objective To explore the clinical characteristics of Bartter syndrome(BS)in children and analyze the characteristics of CLCNKB gene mutation. Methods The clinical data of two unrelated BS family probands and their family members were analyzed. The peripheral blood DNA was extracted with column method. Primers were designed for the coding region of exons of BS-related mutant genes and then amplified. The PCR products were sequenced and compared with the normal sequences in NCBI by BLAST to identify possible gene mutations. Large fragment deletions were detected with multiple ligation probe amplification technique. Results Laboratory tests of both probands showed hypokalemia, alkalosis, hyperreninemia and hyperaldosteroneemia. Large fragment homozygous deletions of exons 1-3, 5-6, 8, 10-11, 13-15 and 17-19 of CLCNKB were detected in pedigree 1, which were inherited from parents. Large fragment deletions of exons 1-3, 5-6, 8, 10-11, 13-15 and 17-19 of CLCNKB and c.1881delC(p.Thr628fs)compound heterozygous mutation were identified in pedigree 2, which were inherited from parents. Conclusion c.1881delC(p.Thr628fs)is a frameshift mutation, which has not been reported at home and abroad. CLCNKB gene mutation is the cause of the two BS families, and the diagnosis is type III classic BS. BS can be clinically identified with molecular genetics to improve the diagnosis rate and to implement timely treatment.

Key words: Bartter syndrome, CLCNKB gene, Gene mutation, Genotype

中图分类号:

Q343.1

胡思翠,孙清,王一冰,孙莉莉,隋炎希,李堂. Bartter综合征二例家系报告与CLCNKB基因突变分析[J]. 山东大学学报 (医学版), 2020, 58(9): 64-70.

HU Sicui, SUN Qing, WANG Yibing, SUN Lili, SUI Yanxi, LI Tang. Analysis of CLCNKB gene mutation in two families with Bartter syndrome[J]. Journal of Shandong University (Health Sciences), 2020, 58(9): 64-70.

参考文献 25

[1]	Walsh PR, Tse Y, Ashton E, et al. Clinical and diagnostic features of Bartter and Gitelman syndromes [J]. Clin Kidney J, 2018, 11(3): 302-309.
[2]	Fulchiero R, Seo-Mayer P. Bartter syndrome and Gitelman syndrome [J]. Pediatr Clin North Am, 2019, 66(1): 121-134.
[3]	黄启亚, 杨彩娴, 李绍清, 等. 经典型Bartter综合征合并代谢综合征的临诊应对[J]. 中华内分泌代谢杂志, 2015, 31(2): 169-171. HUANG Qiya, YANG Caixian, LI Shaoqing, et al. Approach to the patient with typical Bartters syndrome and metabolic syndrome: diagnosis and treatment [J]. Chinese Journal of Endocrinology and Metabolism, 2015, 31(2): 169-171.
[4]	Koulouridis E, Koulouridis I. Molecular pathophysiology of Bartters and Gitelmans syndromes [J]. World J Pediatr, 2015, 11(2): 113-125.
[5]	Seyberth HW, Weber S, Kömhoff M. Bartters and Gitelmans syndrome [J]. Curr Opin Pediatr, 2017, 29(2): 179-186.
[6]	Kim JB. Channelopathies [J]. Korean J Pediatr, 2014, 57(1): 1-18.
[7]	Elrharchi S, Riahi Z, Salime S, et al. Two novel homozygous missense mutations identified in the BSND gene in Moroccan patients with Bartters syndrome [J]. Pediatr Otorhinolaryngol, 2018, 113: 46-50. doi: 10.1016/j.ijporl.2018.07.010.
[8]	Rosanna Fulchiero, Patricia Seo-Mayer. Bartter syndrome and Gitelman syndrome [J]. Pediatr Clin North Am, 2019, 66(1): 121-134.
[9]	Wang C, Chen Y, Zheng B, et al. Novel compound heterozygous CLCNKB gene mutations(c.1755A>G/c.848_850delTCT)cause classic Bartter syndrome [J]. Physiol Renal Physiol, 2018, 315(4): 844-851.
[10]	Seys E, Andrini O, Keck M, Mansour-Hendili L. Clinical and Genetic spectrum of Bartter syndrome Type 3 [J]. Am Soc Nephrol, 2017, 28(8): 2540-2552.
[11]	Alejandro García Castaño, Gustavo Pérez de Nanclares, Madariaga L, et al. Poor phenotype-genotype association in a large series of patients with Type III Bartter syndrome [J]. PLoS One, 2017, 12(3): e0173581.
[12]	顾明敏. 人类遗传性疾病基因诊断的回顾与展望[J]. 诊断学理论与实践, 2010, 9(5): 420-423.
[13]	Cunha TDS, Heilberg IP. Bartter syndrome: causes, diagnosis, and treatment [J]. Nephrol Renovasc Dis, 2018, 11: 291-301. doi: 10.2147/IJNRD.S155397.
[14]	Wongsaengsak S, Vidmar AP, Addala A, et al. A novel SLC12A1 gene mutation associated with hyperparathyroidism, hypercalcemia, nephrogenic diabetes insipidus, and nephrocalcinosis in four patients [J]. Bone, 2017, 97: 121-125. doi: 10.1016/j.bone.2017.01.011.
[15]	Legrand A, Treard C, Roncelin I, et al. Prevalence of novel MAGED2 mutations in antenatal Bartter syndrome [J]. Clin J Am Soc Nephrol, 2018, 13(2): 242-250.
[16]	Gasongo G, Greenbaum LA, Niel O, et al. Effect of nonsteroidal anti-inflammatory drugs in children with Bartter syndrome [J]. Pediatr Nephrol, 2019, 34(4): 679-684.
[17]	Calò LA, Maiolino G. Mechanistic approach to the pathophysiology of target organ damage in hypertension from studies in a human model with characteristics opposite to hypertension: Bartters and Gitelmans syndromes [J]. Endocrinol Invest, 2015, 38(7): 711-716.
[18]	任红, 陈楠. 遗传性肾小管疾病诊治思路[J].中国实用内科杂志, 2014, 34(3):227-230. REN Hong, CHEN Nan. Diagnosis and treatment of inherited renal tubular disease [J]. Chinese Journal of Practical Internal Medicine, 2014, 34(3): 227-230.
[19]	郭静, 唐汇群, 彭芳, 等. 15例婴幼儿Bartter综合征的护理[J]. 国际护理学杂志, 2013, 32(3): 528-529.
[20]	刘长江, 徐美华, 王霄, 等. 误诊为甲状旁腺功能减退症的Bartter综合征临床分析[J]. 临床误诊误治, 2016, 29(11): 56-59.
[21]	周建华. Bartter综合征和Liddle综合征[J]. 中华实用儿科临床杂志, 2018, 33(17): 1289-1292. ZHOU Jianhua. Bartter syndrome and Liddle syndrome [J]. Journal of Applied Clinical Pediatrics, 2018, 33(17): 1289-1292.
[22]	韩玥, 郎艳华, 林毅, 等. 42例3型巴特综合征CLCNKB基因变异分析和基因型/表型研究[J]. 中华肾脏病杂志, 2019, 35(7): 499-506. HAN Yue, LANG Yanhua, LIN Yi, et al. Variant analysis and genotype/phenotype association study in 42 Chinese patients with Bartter syndrome type 3 [J]. Chinese Journal of Nephrology, 2019, 35(7): 499-506.
[23]	崔洁媛, 李春珍, 刘玲, 等. CLCNKB基因复合杂合缺失突变致Bartter综合征1例病例报告[J]. 中国循证儿科杂志, 2018, 13(1): 60-62.
[24]	房国栋. 4-苯丁酸钠可以通过多种途径减少肺表面活性蛋白A2(SP-A2)基因突变引起的细胞内蛋白积聚[D]. 汕头: 汕头大学, 2014.
[25]	刘友平, 严冬梅, 陈川宁, 等. PI3K/Akt调控内质网应激对GRP78的诱导[J]. 中国病理生理杂志, 2011, 27(4): 749-754.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed